Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
Expands ophthalmic eye drop portfolio leveraging market access expertise and newly created US ophthalmic eye drop sales force EYSUVIS complements Systane Preservative-Free by expanding treatment options for dry eye GENEVA–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has signed an agreement to acquire EYSUVIS® … [Read more…]
